Literature DB >> 28288855

Alterations in prefrontal connectivity in schizophrenia assessed using diffusion magnetic resonance imaging.

Vicente Molina1, Alba Lubeiro2, Oscar Soto2, Margarita Rodriguez3, Aldara Álvarez4, Rebeca Hernández4, Rodrigo de Luis-García5.   

Abstract

BACKGROUND: Spatial and biological characteristics of structural frontal disconnectivity in schizophrenia remain incompletely understood. Simultaneous streamline count (SC) and fractional anisotropy (FA) analyses may yield relevant complementary information to this end.
METHODS: Using 3T diffusion magnetic resonance imaging both SC and FA were calculated for the tracts linking lateral and medial subregions of prefrontal cortex (PFC) to cingulate, hippocampus, caudate and thalamus in 27 schizophrenia patients (14 first-episodes) and 27 controls. Relationships of these parameters with cognition, symptoms, treatment doses and illness duration were assessed where significant between-groups differences were detected.
RESULTS: Patients showed lower SC and FA in the tracts linking lateral and medial PFC to thalamus (likely corresponding to anterior thalamic peduncle) and lower FA in those linking PFC to caudate (likely through internal capsule), right caudal anterior cingulate and left hippocampus (likely corresponding to hippocampal-prefrontal pathway). Moreover, patients showed greater SC values for the tracts linking medial PFC and left caudal anterior cingulate. SC and FA values for the tracts linking PFC and caudal anterior cingulate were positively related to motor speed, executive function, problem solving and completed categories in WCST. FA for the tract linking right lateral PFC and caudate was directly related to positive symptoms and FA for the tract linking left medial PFC and left thalamus was inversely related to negative symptoms. Treatment doses were not associated with SC or FA values in any tract. Illness duration was negatively associated with SC and FA in the tracts linking PFC and subcortical areas.
CONCLUSIONS: Widespread alterations in frontal structural connectivity of PFC can be found in schizophrenia, and are related to cognition, symptoms and illness duration.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Connectivity; Diffusion magnetic resonance; Diffusion tensor imaging; Fractional anisotropy; Schizophrenia; Streamline count

Mesh:

Year:  2017        PMID: 28288855     DOI: 10.1016/j.pnpbp.2017.03.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Reduced Microstructural Lateralization in Males with Chronic Schizophrenia: A Diffusional Kurtosis Imaging Study.

Authors:  Faye McKenna; James Babb; Laura Miles; Donald Goff; Mariana Lazar
Journal:  Cereb Cortex       Date:  2020-04-14       Impact factor: 5.357

2.  Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.

Authors:  Johanna Seitz-Holland; Joanne D Wojcik; Suheyla Cetin-Karayumak; Amanda E Lyall; Ofer Pasternak; Yogesh Rathi; Mark Vangel; Godfrey Pearlson; Carol Tamminga; John A Sweeney; Brett A Clementz; David A Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Sinead Kelly; Martha E Shenton; Matcheri S Keshavan; Raquelle I Mesholam-Gately; Marek Kubicki
Journal:  Mol Psychiatry       Date:  2022-08-18       Impact factor: 13.437

3.  Relations between structural and EEG-based graph metrics in healthy controls and schizophrenia patients.

Authors:  Javier Gomez-Pilar; Rodrigo de Luis-García; Alba Lubeiro; Henar de la Red; Jesús Poza; Pablo Núñez; Roberto Hornero; Vicente Molina
Journal:  Hum Brain Mapp       Date:  2018-04-02       Impact factor: 5.038

4.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

5.  Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study.

Authors:  Chih-Ching Wu; Liang-Jen Wang; Yu-Chi Huang; Pao-Yen Lin; Yu Lee; Chi-Fa Hung; Su-Ting Hsu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-19       Impact factor: 2.570

6.  Deficits of entropy modulation in schizophrenia are predicted by functional connectivity strength in the theta band and structural clustering.

Authors:  Javier Gomez-Pilar; Rodrigo de Luis-García; Alba Lubeiro; Nieves de Uribe; Jesús Poza; Pablo Núñez; Marta Ayuso; Roberto Hornero; Vicente Molina
Journal:  Neuroimage Clin       Date:  2018-02-06       Impact factor: 4.881

7.  Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics.

Authors:  João V Nani; Richard S Lee; Camila M Yonamine; Osvaldo A Sant'Anna; Maria A Juliano; Ary Gadelha; Jair J Mari; Mirian A F Hayashi
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

8.  Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.

Authors:  Chunyan Luo; Rebekka Lencer; Na Hu; Yuan Xiao; Wenjing Zhang; Siyi Li; Su Lui; Qiyong Gong
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-29       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.